1. AB0393 Efficacy and Safety of Etanercept (ETN) in Patients with Moderately Active Rheumatoid Arthritis (RA) despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy. (10th June 2014) Authors: Hobbs, K.; Chung, J.; Bitman, B.; Wang, B.; Nussbaum, J.; Collier, D.H. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 936 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0018 The ability of disease activity measures to predict major therapeutic change in us veterans with rheumatoid arthritis. (12th June 2018) Authors: Cannon, G.; Teng, C.-C.; Accortt, N.A.; Collier, D.H.; Lin, T.-C.; Sauer, B.C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0136 Persistence of monotherapy or combination therapy with disease-modifying agents in patients with psoriatic arthritis in a real-world setting. (12th June 2018) Authors: Mease, P.J.; Accortt, N.A.; Rebello, S.; Etzel, C.; Harrison, R.W.; Aras, G.A.; Gharaibeh, M.M.F.; Greenberg, J.D.; Collier, D.H. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0157 Remission in patients with rheumatoid arthritis treated with etanercept (with and without methotrexate) in routine clinical practice as compared to a clinical trial experience. (23rd January 2014) Authors: Keystone, E.C.; Cannon, G.W.; Wang, B.C.; Park, G.S.; Koenig, A.; Collier, D.H. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Open‐label study of etanercept treatment in patients with moderate‐to‐severe plaque psoriasis who lost a satisfactory response to adalimumab. (19th July 2017) Authors: Bagel, J.; Tyring, S.; Rice, K.C.; Collier, D.H.; Kricorian, G.; Chung, J.; Iles, J.; Stolshek, B.S.; Kaliyaperumal, A.; Papp, K.A. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Open‐label study of etanercept treatment in patients with moderate‐to‐severe plaque psoriasis who lost a satisfactory response to adalimumab. (1st August 2017) Authors: Bagel, J.; Tyring, S.; Rice, K.C.; Collier, D.H.; Kricorian, G.; Chung, J.; Iles, J.; Stolshek, B.S.; Kaliyaperumal, A.; Papp, K.A. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0324 Disease activity and patient characteristics by comorbidity among psoriatic arthritis (PSA) patients in a us registry. (12th June 2018) Authors: Mease, P.J.; Litman, H.J.; Accortt, N.A.; Rebello, S.; Greenberg, J.D.; Feng, H.; Gharaibeh, M.M.; Aras, G.A.; Collier, D.H. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗